<DOC>
	<DOCNO>NCT02579551</DOCNO>
	<brief_summary>This clinical trial study effectiveness narrow margin patient low-risk basal cell carcinoma undergo surgery remove skin lesion face . A margin area normal tissue around tumor take surgery make sure cancer remove . This clinical trial study tissue sample determine least amount tissue must remove give acceptable cure rate . This may allow less normal tissue remove patient may less expensive surgery .</brief_summary>
	<brief_title>Effectiveness Narrow Margins Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine success rate narrow margin excision low-risk facial basal cell carcinoma ( BCC ) . SECONDARY OBJECTIVES : I . To determine narrow excision margin low-risk facial BCC give acceptable ( 95 % ) cure rate 3 year follow-up period .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<criteria>1 . Location 1 . Area M ( cheek , forehead , scalp &amp; neck ) tumor size &lt; 10 mm 2 . Area H ( central face , eyelid , eyebrow , periorbital , nose , lip , chin , mandible , preauricular &amp; postauricular , temple &amp; ear ) tumor size &lt; 6 mm 2 . Welldefined border 3 . Primary BCC 4 . Patient immunosuppressed 5 . There prior radiotherapy site 6 . Nodular subtype 7 . No perineural involvement ( neurological deficit grossly ) 1 . Location 1 . Area M tumor size &gt; = 10 mm 2 . Area H tumor size &gt; = 6 mm 2 . Poorly define border 3 . Recurrent BCC 4 . Patient immunosuppressed 5 . There prior radiotherapy site</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>